Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough

FEMS Immunology and Medical Microbiology

Volumn 13, Issue 2, 1996, Pages 169-178

  Williamson, Peter ^a   Matthews, Ruth ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bordetella pertussis; Epitope map; Fim2; Fim3

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; IMMUNOGLOBULIN A; PERTUSSIS VACCINE;

ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; PERTUSSIS; PRIORITY JOURNAL; SERODIAGNOSIS; VACCINATION;

EID: 0030002320     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(95)00123-9     Document Type: Article

References (27)

1. Preston, N.W. (1986) Recognising whooping cough. Br. Med. J. 292, 901-902
2. Miller, E., Vurdien, J.E. and While, J.M. (1992) The epidemiology of pertussis in England and Wales. Comm. Dis. Rep. 2, R152-154.
3. Robinson, A., Irons, L.I. and Ashworth, L.A.E. (1985) Pertussis vaccine: Present status and future prospects. Vaccine 3. 11-19.
4. Preston, N.W. (1994) Pertussis vaccination. Neither panic nor complacency. Lancet 344, 491-492.
5. Manclark, C.R. (1991) Proceedings of an informal consultation on the World Health Organisation requirements for Diphtheria, Tetanus, Pertussis and combined vaccines. Dept. of Health and Human Services, US Public Health Service. Bethesda. Maryland. DHHS Publication No. (FDA) 91-1174, 252 pp.
6. Syedabubakar, S.N., Matthews, R.C., Preston, N.W., Owen, D. and Hillier, V. (1995) Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK. Epidemiol. Infect. 115, 101-113.
7. Miller, E., Ashworth, L.A.E., Robinson, A., Waight, P.A. and Irons, L.I. (1991) Phase II trial of the whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Lancet 337, 70-73.
8. Edwards, K.M. (1992) Acellular pertussis vaccine - A solution to the pertussis problem? J. Infect. Dis. 168, 15-20.
9. Gorringe, A.R., Ashworth, L.A.E., Irons, L.I. and Robinson, A. (1985) Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells. FEMS Microbiol. Lett. 26, 5-9.
10. Zhang, J.M., Cowell, J.L., Steven, A.C. and Manclark, C.R. (1985) Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. In: Proceedings of 4th International Symposium on Pertussis. Develop. Biol. Standard 61, 173-185.
11. Ashworth, L.A.E., Robinson, A., Funnell, S., Gorringe, A.R., Irons, L.I. and Seabrook, R.N. (1988) Agglutinogens and fimbriae of Bordetella pertussis. Tokai J. Exp. Clin. Med. 13, suppl, 203-210.
12. Robinson, A., Gorringe, A.R., Funnell, S.G.P. and Fernandez, M. (1989) Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 7, 321-324.
13. Oda, M., Cowell, J.L., Burstyn, D.G., Thaib, S. and Manclark, C.R. (1985) Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect. Immun. 47, 441-445.
14. Stanbridge, T.N. and Preston, N.W. (1974) Experimental pertussis infection in the marmoset - type specificity of active immunity. J. Hyg. Camb. 72, 213-228.
15. MRC. (1959) Vaccination against whooping cough - final report. Br. Med. J. 1, 994-1000.
16. Preston, N.W. (1976) Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J. Hyg. Camb. 77, 85-91.
17. Preston, N.W. (1963) Type-specific immunity against whooping cough. Br. Med. J. ii, 724-726.
18. Livey, I., Duggleby, C.J. and Robinson, A. (1987) Cloning and nuceotide sequence analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Molec. Microbiol. 2, 203-209.
19. Mooi, F.R., Avest. A., and van der Heide, H.G.J. (1990) Structure of the Bordelella pertussis gene encoding the serotype 3 fimbrial subunit. FEMS Microbiol. Lett. 66, 327-332.
20. Preston NW. (1985) Essential immunogens in human pertussis: the role of fimbriae. Dev. Biol. Stand 61, 137-141
21. Geysen, H.M., Rodda, ST., Mason, T.J., Tribbick, G. and Schoofs, P.G. (1987) Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods 102, 259-274.
22. Preston, N.W. (1970) Technical problems in the laboratory diagnosis and prevention of whooping cough. Lab. Practice 19, 482-486
23. Al-Dughaym, A.M., Matthews, R.C. and Burnie, J.P. (1994) Epitope mapping human Heat Shock Protein 90 with sera from infected patients. FEMS Immunol. Med. Microbiol. 8. 43-48.
24. Begg, R.C., (1984) Pertussis - New Zealand 1982/83. N.Z. Med. J. 97, 408-411.
25. Preston, N.W. and Stanbridge, T.N. (1972) Efficacy of pertussis vaccines: a brighter horizon. Br. Med. J. 3, 448-451.
26. Pearce, A.M., Seabrook, R.N., Irons, L.I., Ashworth, L.A.E., Atkinson, T. and Robinson, A. (1994) Localization of antigenie domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae. Microbiol. 140, 205-211.
27. Stanbridge, T.N. and Preston, N.W. (1974) Variation of serotype in strains of Bordetella pertussis. J. Hyg., Camb, 73, 305-310.